Adjuvant therapy for colorectal cancer in 2020: has anything changed this millennium?

被引：1
|
作者：
Bridgewater, J. [1 ]
机构：
[1] UCL Canc Inst, Dept Oncol, London, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷 / 04期
关键词：
III COLON-CANCER; STAGE-II; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; CHEMOTHERAPY; SURVIVAL;
D O I：
10.1016/j.annonc.2020.01.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：447 / 448
页数：2
相关论文
共 50 条
  • [31] Adjuvant Therapy in Colon Cancer
    Reinacher-Schick, Anke
    Arnold, Dirk
    Trarbach, Tanja
    Ridwelski, Karsten
    Bruch, Hans-Peter
    Kirchner, Thomas
    Kubicka, Stefan
    Schmoll, Hans-Joachim
    ONKOLOGIE, 2010, 33 : 2 - 7
  • [32] Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
    Han, Sae-Won
    Lee, Hyun-Jung
    Bae, Jeong Mo
    Cho, Nam-Yun
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Oh, Do-Youn
    Im, Seock-Ah
    Bang, Yung-Jue
    Jeong, Seung-Yong
    Park, Kyu Joo
    Park, Jae-Gahb
    Kang, Gyeong Hoon
    Kim, Tae-You
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (09) : 2209 - 2216
  • [33] Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer
    Al Sabbagh, Chantal
    Seguin, Johanne
    Agapova, Elena
    Kramerich, Dounia
    Boudy, Vincent
    Mignet, Nathalie
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 157 : 154 - 164
  • [34] Sex differences in recovery from postoperative sarcopenia during adjuvant CAPOX therapy for colorectal cancer
    Nozawa, Hiroaki
    Abe, Shinya
    Abe, Kentaro
    Yokota, Yumi
    Hori, Shunsuke
    Yakabe, Mitsutaka
    Sasaki, Kazuhito
    Emoto, Shigenobu
    Yokoyama, Yuichiro
    Sonoda, Hirofumi
    Murono, Koji
    Matsuzaki, Hiroyuki
    Nagai, Yuzo
    Shinagawa, Takahide
    Akishita, Masahiro
    Ishihara, Soichiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (10)
  • [35] The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyridine Single Therapy to the Oxaliplatin Regimen
    Teranishi, Nobuhisa
    Uetake, Hiroyuki
    CANCERS, 2025, 17 (03)
  • [36] Prognostic Impact of Microsatellite Instability in Colorectal Cancer Patients Treated with Adjuvant FOLFOX
    Des Guetz, G.
    Lecaille, C.
    Mariani, P.
    Bennamoun, M.
    Uzzan, B.
    Nicolas, P.
    Boisseau, A.
    Sastre, X.
    Cucherousset, J.
    Lagorce, C.
    Schischmanoff, P. O.
    Morere, J. F.
    ANTICANCER RESEARCH, 2010, 30 (10) : 4297 - 4301
  • [37] Response to Chemotherapy in Metastatic Colorectal Cancer After Exposure to Oxaliplatin in the Adjuvant Setting
    Moreau, Louis-Charles
    Rajan, Raghu
    Thirlwell, Michael P.
    Alcindor, Thierry
    ANTICANCER RESEARCH, 2013, 33 (04) : 1765 - 1768
  • [38] A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
    Okuno, Keisuke
    Kandimalla, Raju
    Mendiola, Marta
    Balaguer, Francesc
    Bujanda, Luis
    Fernandez-Martos, Carlos
    Aparicio, Jorge
    Feliu, Jaime
    Tokunaga, Masanori
    Kinugasa, Yusuke
    Maurel, Joan
    Goel, Ajay
    MOLECULAR CANCER, 2023, 22 (01)
  • [39] An SNP Marker Predicts Colorectal Cancer Outcomes with 5-Fluorouracil-Based Adjuvant Chemotherapy Post-Resection
    Chien, Hao
    Chu, Yu-De
    Hsu, Yi-Ping
    Yeh, Chau-Ting
    Lai, Ming-Wei
    Chang, Ming-Ling
    Lim, Siew-Na
    Chen, Chun-Wei
    Lin, Wey-Ran
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [40] Early-stage breast cancer treatment disparities in the Midsouth: Has anything changed?
    Moten, Ambria S.
    Grande, Payton
    Hendrix, Ashley
    Fleming, Martin D.
    AMERICAN JOURNAL OF SURGERY, 2023, 226 (04) : 447 - 454
12345